glutathione protocol for parkinsons Gut microbiota and Parkinson's disease: exploring pathogenesis and potential therapeutic strategies from a gut-brain axis perspective Parkinson's Disease Treatment | IV
Description
The patients received intravenous A1AT twice weekly for 4 weeks as a first-line treatment
The GSH content of the rat liver is expected to be ~6 mol/g (mM) [9, 14], although levels in the range of 3.6 to 7.7 mM have been reported in different studies [9, 18]
Mol Cancer 16 , 76, (2017)
Y.WuH.TjeerdemaR
As part of its anti-inflammatory effect, GHK-Cu is known to suppress free radicals, thromboxane formation, transforming growth factor beta-1, tumor necrosis factor-alpha, and protein glycation
